BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18788302)

  • 21. Antitumor effects of radioiodinated antisense oligonuclide mediated by VIP receptor.
    Ou X; Tan T; He L; Li Y; Li J; Kuang A
    Cancer Gene Ther; 2005 Mar; 12(3):313-20. PubMed ID: 15578065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
    Fu P; Shen B; Zhao C; Tian G
    J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the hepatobiliary excretion of technetium-99m-MAG3 and reconstitution factors affecting radiochemical purity.
    Shattuck LA; Eshima D; Taylor AT; Anderson TL; Graham DL; Latino FA; Payne SE
    J Nucl Med; 1994 Feb; 35(2):349-55. PubMed ID: 8295009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA.
    Zhang YM; Liu N; Zhu ZH; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med; 2000 Nov; 27(11):1700-7. PubMed ID: 11105827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preparation of liposome-mediated 99m-technetium-labeled antisense oligonucleotides of c-myc mRNA].
    Zheng J; Tan T; Zhang C; Li Y; Liang Z; Tu J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Dec; 20(4):704-7. PubMed ID: 14716882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of alternative methods of preparing 99mTc-MAG3.
    Seetharaman S; Sosabowski MH; Ballinger JR
    Appl Radiat Isot; 2007 Nov; 65(11):1240-3. PubMed ID: 17434313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3'-99mTc-labeling and biodistribution of a CAPL antisense oligodeoxynucleotide.
    Hjelstuen OK; Tønnesen HH; Bremer PO; Verbruggen AM
    Nucl Med Biol; 1998 Oct; 25(7):651-7. PubMed ID: 9804046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Labeling peptides with technetium-99m using a bifunctional chelator of a N-hydroxysuccinimide ester of mercaptoacetyltriglycine.
    Hnatowich DJ; Qu T; Chang F; Ley AC; Ladner RC; Rusckowski M
    J Nucl Med; 1998 Jan; 39(1):56-64. PubMed ID: 9443739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
    Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
    Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biodistribution studies of carbohydrate derivatives radiolabeled with technetium-99m.
    de Barros AL; Cardoso VN; Mota Ld; Alves RJ
    Bioorg Med Chem Lett; 2010 Jan; 20(1):315-7. PubMed ID: 19926278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on the antisense inhibition effect of liposome-mediated radiolabled antisense oligonucleotides of c-myc mRNA].
    Zheng J; Tan T; Pan W; Zhang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):413-6. PubMed ID: 12910676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human polyclonal immunoglobulin labelled with technetium-99m via NHS-MAG3: a comparison of radiochemical behavior and biological efficacy with other labelling methods.
    Gano L; Patrício L; Marques E; Cantinho G; Pena H; Martins T; Hnatowich DJ
    Nucl Med Biol; 1998 May; 25(4):395-403. PubMed ID: 9639302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide.
    Decristoforo C; Mather SJ
    Bioconjug Chem; 1999; 10(3):431-8. PubMed ID: 10346875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
    Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
    J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organ distribution of 99m-Tc-and 51-Cr-labelled thymocytes.
    Barth RF; Singla O
    J Nucl Med; 1975 Jul; 16(7):633-8. PubMed ID: 1151482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of 99mTc-labeled oligonucleotides.
    Hnatowich DJ
    Q J Nucl Med; 1996 Sep; 40(3):202-8. PubMed ID: 8961799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimized preparation of a (99m)Tc-radiolabeled probe for tracing microRNA.
    Kang L; Xu XJ; Ma C; Wang RF; Yan P; Zhang CL; Sun HW; Li D
    Cell Biochem Biophys; 2015 Mar; 71(2):905-12. PubMed ID: 25315639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyridine-containing 6-hydrazinonicotinamide derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules.
    Purohit A; Liu S; Ellars CE; Casebier D; Haber SB; Edwards DS
    Bioconjug Chem; 2004; 15(4):728-37. PubMed ID: 15264859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation and biodistribution of VIP-125I-ASON].
    Ou XH; Tan TZ; Li YC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):713-6. PubMed ID: 16235546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved synthesis and biological evaluation of Tc-99m radiolabeled AMO for miRNA imaging in tumor xenografts.
    Kang L; Fan Z; Sun H; Feng Y; Ma C; Yan P; Zhang C; Ma H; Hao P; Chen X; Zheng Z; Xu X; Wang R
    J Labelled Comp Radiopharm; 2015; 58(13-14):461-8. PubMed ID: 26503645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.